What is the Point of Parliamentary Questions
B420 is the probiotic strain in the formula, and the published 6-month RCT in 225 overweight and obese adults reported a body fat mass difference of -4.0% versus placebo (P=0.002), a 2.4 cm waist circumference reduction more than placebo, and a daily energy intake reduction of approximately 300 kcal compared to placebo (post-hoc factorial analysis).[9] The trial did not select for GLP-1 users, did not measure constipation as an endpoint, and the available evidence is at the ingredient-level human evidence tier
A recent study from British Columbia, Canada, explored the effects of GLP-1 receptor agonists in nearly 11,000 patients with both autoimmune conditions and diabetes
& Szarska, E
North America Glucagon-like Peptide-1 Agonists Top Companies AstraZeneca Sanofi Eli Lilly and Company Pfizer Novo Nordisk *Disclaimer: Top companies sorted in no particular order North America Glucagon-like Peptide-1 Agonists Market Concentration North America Glucagon-like Peptide-1 Agonists Company List Adocia SA Amgen AstraZeneca Boehringer Ingelheim Biocon Ltd Eli Lilly and Company Hanmi Pharmaceutical Co
(152) examined the correlation between bone loss during spaceflight and gut microbiome, as well as specific host metabolites